In contrast to the alterations observed in CAND1 cKO mice, hepatocyte-specific overexpression of CAND1 substantially protected against HFD-induced hepatic steatosis, hepatic resistance and inflammation. The gene discussed is CAND1; the disease is fatty liver disease.